News and Press Releases Archives - World Stem Cell Summit World Stem Cell Summit

August 20, 2019

$4.96 million CIRM grant awarded to Sanford Burnham Prebys to help the tiniest patients

The California Institute for Regenerative Medicine (CIRM) has awarded a $4.96 million grant to Sanford Burnham Prebys Professor Evan Y. Snyder, M.D., Ph.D. The funding will allow Snyder to complete pre-investigational new drug (IND)-enabling studies, a step toward securing U.S. Food & Drug Administration (FDA) approval of a human trial for neural stem cells as […]

August 17, 2019

Your New Heart Could Be Made in China

Chinese labs have fewer compunctions about animal research. Photographer: STR/AFP/Getty Images The country’s researchers are racing to grow replacement organs for humans in animals. By Adam Minter – Bloomberg News Recently, a Chinese startup named Qihan Biotech raised $20 million to develop replacement organs for humans. The smallish deal would hardly have rated a headline, except […]

August 17, 2019

McGowan Institute Partners with International Space Station to Advance Regenerative Medicine

KENNEDY SPACE CENTER, Fla. – The International Space Station (ISS) U.S. National Laboratory is embarking upon a multi-year research alliance with the McGowan Institute for Regenerative Medicine (MIRM) at the University of Pittsburgh (Pitt) to push the limits of biomedical research and development aboard the orbiting laboratory. The alliance — a core element of the […]

Human amniotic fluid stem cells show promise in treating severest type of spinal bifida

August 14, 2019

Human amniotic fluid stem cells show promise in treating severest type of spina bifida

Durham, NC – A study released today in STEM CELLS Translational Medicine provides compelling evidence of how an injection of human amniotic fluid stem cells can be used to protect the spinal cord of a fetus from myelomeningocele (MMC). The finding could lead to a new strategy for treating this debilitating birth defect that affects […]

August 13, 2019

The ISSCR Releases Informed Consent Standard for Stem Cell-based Interventions

12 August 2019 — The International Society for Stem Cell Research (ISSCR) today released a professional standard of informed consent for stem cell-based interventions performed outside of formal clinical trials, such as the unapproved and unproven “treatments” offered by clinicians at direct-to-consumer clinics. The standard is meant to help ensure that patients are informed about […]

August 12, 2019

Inaugural World Stem Cell Summit-CHINA & Phacilitate Leaders Asia Will Foster Understanding And Collaborations Accelerating Regenerative Medicine

REGISTER HERE Registration is now open for the Shanghai meeting, October 15-16, 2019 Shanghai, August 12, 2019 – Combining more than 30 years of conference experience, Phacilitate and the nonprofit Regenerative Medicine Foundation (RMF) have created a new Asia forum for global biomedical professionals and investors focused on advanced therapies, regenerative medicine and […]

August 7, 2019

Consumer Alert! ISCT issues patient advice and concern on unproven CAR-T-cell preservation services

Vancouver, Canada, August 7, 2019 – ISCT, the International Society for Cell and Gene Therapy, the global professional society of clinicians, researchers, regulatory specialists, technologists and industry partners in the cell and gene therapy sector, today announces its objection to linking the benefits of cellular immunotherapy, in particular Chimeric Antigen Receptor (CAR) T-cell therapy, with […]

August 5, 2019

F.D.A. Can Act Against Stem Cell Clinic, Judge Rules

A Florida judge says the agency is entitled to an injunction against a stem cell clinic that has blinded patients and challenged the government’s authority to regulate it. By Denise Grady – The New York Times – Link to Full Article June 3, 2019 – A federal judge on Monday struck a blow against the […]

July 26, 2019

LADL is the new technology for controlling DNA folding

July 25, 2019

California stem-cell agency’s supporters reveal plan for $5.5-billion ballot initiative

June 23, 2019

A New Frontier for Understanding Fatty Liver Disease

The Context: Fatty liver diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic stereohepatitis (NASH), and Wolman disease are especially difficult to study and treat due to the lack of effective disease models that recapitulate their characteristics and allow for effective drug development. Inflammation is known to play an important role in these diseases, but […]